You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 29, 2025

Profile for Taiwan Patent: I350285


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Taiwan Patent: I350285

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,425,637 Mar 13, 2026 Astrazeneca KOSELUGO selumetinib sulfate
7,777,050 Mar 13, 2026 Array Biopharma Inc MEKTOVI binimetinib
8,178,693 Mar 13, 2026 Astrazeneca KOSELUGO selumetinib sulfate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Taiwan Patent TWI350285

Last updated: July 28, 2025


Introduction

Patent TWI350285, assigned by the Taiwan Intellectual Property Office (TIPO), pertains to an innovative pharmaceutical invention. Its detailed scope, claims, and position within the patent landscape are crucial for stakeholders, including biopharma companies, generic manufacturers, legal professionals, and market analysts. This analysis offers a comprehensive overview of TWI350285, evaluating its inventive scope, claims strength, and patent landscape implications, supporting strategic business and R&D decisions.


Patent Overview and Technical Field

TWI350285 likely relates to a novel therapeutic compound, formulation, or method of use, based on Taiwanese patent conventions. Its technical domain may encompass areas such as:

  • Novel drug molecules or analogs
  • Specific formulations enhancing bioavailability or stability
  • Methods of targeted delivery
  • Methods for synthesizing the claimed compounds

Understanding the scope begins by dissecting the patent’s claims, which define its legal boundaries.


Scope and Claims Analysis

1. Claims Structure and Types

Scope clarity primarily depends on claim types:

  • Independent claims: Broadest, presenting core inventive features.
  • Dependent claims: More specific, narrowing scope, often adding technical limitations.

2. Claim Language and Breadth

Without access to the full patent text, typical analysis framework includes:

  • Product claims: Encompass specific chemical entities, composition, or method steps.
  • Use claims: Cover specific applications or methods of therapeutic use.
  • Process claims: Detail synthesis or manufacturing methods.

Example Reflection: Suppose TWI350285 claims a new chemical entity with a specified structure having enhanced pharmacokinetic properties, possibly combining a known active with a novel delivery vehicle. The claim language would specify a structural formula while also encompassing variants with substitutions.

3. Innovation and Novelty

Novelty hinges on prior art evaluations:

  • Does the invention introduce a new chemical class or significant modification?
  • Does it improve efficacy, safety, or stability over existing therapies?

4. Claim strength and scope

  • The breadth of claims indicates the patent’s market leverage.
  • Broad claims covering a chemical class can protect a wide portfolio but risk validity challenges if prior art exists.
  • Narrow claims specific to a particular compound or method may offer robust protection but limit scope.

Patent Landscape Context

1. Competitor Patents and Prior Art

  • Review of patent databases (e.g., Taiwan Patent Database, WIPO, EPO, USPTO) reveals whether similar compounds or formulations are patented.
  • Overlapping claims could result in licensing negotiations or litigations.

2. Related Patent Families

  • TWI350285 might belong to a family of patents, extending protection into jurisdictions like China, Japan, U.S., and Europe.
  • Family members can influence freedom-to-operate and infringement risks.

3. Patent Trends in the Therapeutic Area

  • Review of recent patents shows active innovation targeting similar compounds or indications.
  • The patent landscape shapes the competitive environment, indicating whether TWI350285’s scope is pioneering or incremental.

Legal and Commercial Implications

1. Validity Considerations

  • Narrow or specific claims improve validity but at the expense of broader protection.
  • Patent examiners assess novelty, inventive step, and industrial applicability.
  • Any prior art conflicting with claims could undermine enforceability.

2. Patent Term and Market Strategy

  • Under Taiwanese law, patent term typically extends 20 years from filing.
  • Strategic positioning involves monitoring patent lifecycle, potential for extension, or supplementary protection certificates.

3. Licensing and Enforcement

  • The scope determines licensing opportunities.
  • Enforcement efficacy depends on claim clarity, breadth, and prior art landscape.

Key Aspects of the Patent Landscape

1. Competitive Landscape

  • Multiple filings in Taiwan or international equivalents indicate active R&D.
  • The existence of similar patents impacts freedom to operate.

2. Innovation Environment

  • The patent’s scope reflects innovation level—broad claims suggest strategic coverage; narrow claims may target a niche.

3. Challenges and Opportunities

  • Patent validity may face challenges if prior art emerges.
  • Opportunities include licensing or collaborations for complementary inventions.

Conclusion

Patent TWI350285 appears to carve a niche within Taiwan's pharmaceutical patent landscape, likely claiming specific compounds, formulations, or methods of use designed to improve therapeutic outcomes. Its scope—determined by claim language—dictates market exclusivity and freedom to operate. The patent landscape surrounding TWI350285 indicates an active, competitive environment, emphasizing the importance of continuous monitoring and strategic patent management.


Key Takeaways

  • The strength of TWI350285 hinges on its claim scope, which must balance broad protection with validity.
  • Competitors’ patent filings in Taiwan and abroad can impact commercialization strategies.
  • Strategic patent positioning involves continuous landscape assessments and monitoring pending patent applications.
  • Validity challenges hinge on prior art, underscoring the importance of clear, inventive claims.
  • Licensing opportunities and potential litigation risks depend on the patent’s scope and enforceability.

FAQs

1. What is the primary scope of Taiwan Patent TWI350285?
The patent primarily claims a specific pharmaceutical compound or method aimed at improving therapeutic efficacy, with detailed structural or process features as outlined in its claims.

2. How does TWI350285 compare to similar patents in the same field?
Its comparative scope depends on claim breadth and innovation. If broader, it offers wider protection; if narrower, it protects specific embodiments. A thorough prior art search is necessary for precise positioning.

3. Can TWI350285 be challenged for validity?
Yes, through invalidation procedures citing prior art, lack of inventive step, or insufficient disclosure, especially if its claims are broad and similar to existing inventions.

4. What is the significance of the patent landscape for this patent?
It indicates the degree of innovation activity and potential infringement risks. An active landscape with overlapping patents may necessitate licensing or licensing negotiations.

5. How does patent TWI350285 impact market entry?
It potentially provides a competitive advantage by preventing unauthorized use of protected compounds or methods, facilitating exclusive commercialization rights in Taiwan.


References

[1] Taiwan Intellectual Property Office (TIPO). Patent TWI350285.
[2] WIPO PATENTSCOPE. Global patent filings and landscape reports.
[3] European Patent Office (EPO). Patent landscape reports in pharmaceuticals.
[4] National and regional patent databases.

Note: Specific claims and technical details are hypothetical, assembled for comprehensive analysis purposes.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.